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The aim is to explore the eﬀect of acupuncture on Th1, Th2 cytokines in rats of implantation failure. Early pregnant rats were
randomized into normal group (N), implantation failure group (M),acupuncture group (A),progestin group (H). The model was
established with mifepristone. Samples of serum, endometrium were collected on Day 5, 6 and 8 of pregnancy. Compared with
group M, the number of embryos was signiﬁcantly higher in groups N, A and H; IL-1β, IL-2 protein in serum and endometrium
were signiﬁcantly lower in groups N, A and H, while IL-4, IL-10 were signiﬁcantly higher in groups N, A and H; the endometrial
IL-2, IL-4 mRNA were signiﬁcantly lower in groups N, A and H, while IL-1β, IL-10 mRNA were signiﬁcantly higher in groups N,
A and H. Acupuncture could improve the poor receptive state of endometrium due to mifepristone by promoting Th2 cytokines
secretion and inhibiting Th1 cytokines to improve blastocyst implantation.
1.Introduction
Inrecentyears,theassistedreproductivetechnologyhasbeen
greatly improved, but the success rate is still not high. The
primary reason is blastocyst implantation failure. Implan-
tation is one of the most important procedures in repro-
duction and the key for the success of pregnancy. In the
process of blastocyst implantation, in order to adapt to the
blastocyst adhesion, intrusive, growth, and development, the
endometrium suﬀers complex changes including cell pro-
liferation, diﬀerentiation, migration, and apoptosis. Vari-
ous molecules are participating in this process. Thus, the
crosstalk between the active blastocyst and receptive uterus
is essential to implantation [1]. It is crucial to take timely
modiﬁcations in the endometrium to become receptive to
the developing embryo for successful implantation. [2]. The
human endometrium becomes receptive to the embryo only
for a limited period during the luteal phase of the menstrual
cycle, under the inﬂuence of steroid hormones and paracrine
factors originating from endometrial cells and the embryo
[3]. Impaired endometrial receptivity is considered to be a
major limiting factor for the establishment of pregnancy [4].
The regulation of endometrial changes is not exclusively by
ovarian hormones, the immune system has been implicated
in normal endometrial function, similar to processes tak-
ing place during inﬂammatory and reparative path. Thus,
cytokines and immune cells play a major role in endometrial
tissue regeneration, growth, diﬀerentiation, and shedding
throughout the normal menstrual cycle and in remodelling
during embryonic implantation and growth [5–7].
Cytokines play a critical role in pregnancy, particularly in
the early stages during blastocyst implantation and placental
development [8–13]. For some years, a prevalent theory has
been that predominant production of so-called T helper
type 2 (Th2) cytokines such as interleukin (IL)-4 and IL-
10 was characteristic of normal implantation and pregnancy,
whereas in miscarriage, and recurrent miscarriage there was
a predominant production of Thl cytokines such as IL-1 and
IL-2 [14]. Therefore in the process of location, adhesion, and
penetration, the endometrium not only has the morphologic
changesbutalsohasalterationintheexpressionofcytokines.
Repeated failures of in vitro fertilization and embryo
transfer (IVF-ET) bring huge economic and psychological
burden to infertility patients, therefore, we are expecting an
economic and eﬀective method to ameliorate implantation.
A research has shown that acupuncture on the day of ET2 Evidence-Based Complementary and Alternative Medicine
signiﬁcantly improves the reproductive outcome of IVF,
compared with no acupuncture [15]. Acupuncture seems
to be a useful tool for improving pregnancy rate after
assisted reproduction therapy [16]. Previous researches have
proven that acupuncture treatment is eﬀective for blastocyst
implantation obstacle, butthe mechanism is still not clear, so
the aim of the experiment is to explore the possible way that
acupuncture improves implantation and to provide more
supports for rationale.
2.MaterialsandMethods
2.1. Animals and Grouping. Virgin, 10-week-old, weight
210 ∼ 230g female Wistar rats (n = 90) and reproductive
adult male Wistar rats (n = 40), weight 250 ∼ 300g, SPF
grade were provided by the CDC of Hubei province (the ani-
mal certiﬁcate SCXK no. 2008-0005) and fed in the barrier
system according to the institutional guidelines established
by the Animal Care and Use Committee of Tongji Medical
College, Huazhong University of Science and Technology.
After adaptive feeding for 5 days, female rats were mated
with male rats at 6 PM with the scale of 2:1 and checked
the vaginal smear at 8 AM the next day (D1 = sperm on the
vaginal smear detection). The pregnant rats were random-
ized into normal group (N), implantation failure group (M),
acupuncture treatment group (A), and progestin treatment
group (H), with 18 rats in each group. Then, the 18 rats
w e r ee q u a l l yr a n d o m i z e di n t oD 5g r o u p( n = 6), D6 group
(n = 6),D8group(n = 6)accordingtothetimeofsampling.
2.2. Reagent and Main Devices. The mifepristone tablets
(Beijing Zizhu Pharmaceutical Co., Ltd. China) and pro-
gestin (Zhejiang Xianju Pharmaceutical Co., Ltd. China)
were provided by Tongji Hospital. DAB coloring reagent
kit used for immunohistochemistry was product of Beijing
Zhongshan Biotech Co., Ltd. China. Tissue protein extrac-
tion (AR0101-100) and BCA protein assay kits (AR0146)
were purchased from Wuhan BOSTER Company, China.
Cocktail protease inhibitor was purchased from Wuhan
Gugeshengwu Technology Co., Ltd. China. Rat IL-1β,I L -
2, IL-4, and IL-10 enzyme-linked immunosorbent assay
(ELISA) kits were purchased from Beijing NeoBioscience
Technology Co., Ltd. China. The total RNA extract reagent
(Trizol), PrimeScript RT reagent Kit Perfect Real Time
(TaKaRa Code: DRR037A), and SYBR Premix Ex Taq
(TaKaRa Code: DRR041) were purchased from TaKaRa
Biotechnology(Dalian)Co.,Ltd.Dalian,China.Rabbitpoly-
clonal to IL-1 beta (ab9787), IL-2 (ab25104), IL-4 (ab9811),
and IL-10 (ab9969) was purchased from Abcam Company,
USA. Goat or rabbit anti-rat Actin polyclonal antibody (sc-
1616R) was purchased from Santa Cruz Biotechnology, Inc.
California, USA. DyLight 800-Labeled Antibody To Rabbit
IgG (H + L) (Cat. No 072-07-15-06) was purchased from
KPL, Inc. Maryland, USA. HRP-Goat anti-Rabbit IgG (H
+ L) Conjugate (Cat. No. ANT011) was purchased from
AntGene Biotech Co., Ltd. China. Nucleic Acid/Protein
Analyzer (DU730, BECKMAN COULTER, Inc., Fullerton,
California, USA); Mastercycler gradient PCR apparatus
(Eppendorf Company, Germany); Canon Micro-imaging
System (Canon 350 D, Japan); Applied Biosystems StepOne
Real-Time PCR System (Applied Biosystems, California,
USA); Microplate reader (BioTek Synergy2, Vermote, USA);
Near infrared double-color laser imaging system (Odyssey
LI-COR Inc, USA).
2.3. Modeling and Treatment. The mifepristone tablet was
dissolved in an appropriate amount of edible sesame oil after
tripsis to produce 2mg/mL mifepristone solution. The rats
in groups M, A, and H were given mifepristone solution
at 5.5mg/kg by neck subcutaneous injection on D1 at 9
AM,whilegroupNwereinjectedwithcorresponding sesame
oil. Group A started acupuncture treatment which selected
bilateral “Housanli” (ST 36) and “Sanyinjiao” (SP 6) as the
acupoints [17] from D1 at 3 PM and the rats were ﬁxed
by self-made cloth bags. Acupuncture methods: continuous
25min per day, rolling the needle every 5min, and treatment
for 5–8 days by the same investigator for all the rats in group
A. Group N and M were ﬁxed for 25min at daily 3 PM for 5–
8d a y s .G r o u pHb e g a np r o g e s t i nt r e a t m e n t( 4 0m g / k g / d a y ,
im)f r o mD 1f o r5 – 8d a y s .
2.4. Sampling. T h er a t sw e r en a r c o t i z e dw i t h1 %p e n t a b a r -
bital sodium by intraperitoneal injection at 4 PM on D5, D6,
and D8 for each group. Uterus was taken out by laparotomy
and ﬂushed with normal saline. Part of the uterus was ﬁxed
in 4% paraformaldehyde solution for paraﬃn embedding,
while other part was preserved in −80◦Cr e f r i g e r a t o rf o r
future use. Blood was drawn from aorta abdominalis.
After centrifuging at 3000r/min for 20min, the serum was
collected and stored in a −80◦Cr e f r i g e r a t o r .
2.5. ELISA for IL-1β, IL-2, IL-4, and IL-10 Protein Expres-
sion in Serum and Endometrium. A quantitative sandwich
enzyme immunoassay technique was used in accordance
with the manufacturer’s protocol. The sensitivity of the
ELISA kits was 15pg/mL. None of the samples examined had
a cytokine level >2000 pg/ml. The inter-assay and intra-assay
coeﬃcients of variation of the ELISA kits were less than 9%.
2.6. Immunohistochemistry for Endometrial IL-1β,I L - 2 ,a n d
IL-4 Protein Detection. The paraﬃn slides were kept in oven
at 60◦C for 1 hour. Then, the sections were deparaﬃnized
in xylene and rehydrated through grades of ethanol in
distilled water, rinsed with PBS three times (5min each).
After that, antigens were retrieved by microwave processing
with 10mM Na-citrate (pH 6.0) at 92–98◦C for 20min.
After natural cooling to room temperature, rinsed in PBS,
endogenousperoxidaseactivitywasquenchedwith3%H2O2
in PBS for 10min, followed by washing in PBS, three times,
5min each. Sections were blocked with 1% Bovine Serum
Albumin (BSA) for 30min. Excess BSA was drained. These
sections were then incubated in respective primary antibody
overnight at 4◦C in a humidiﬁed chamber. For the negative
control, slide was incubated in PBS. Primary antibodies
against IL-1β, IL-2, and IL-4 raised in rabbit were used at
1:50dilution.AfterbeingrinsedinPBST(0.1%Tween-20inEvidence-Based Complementary and Alternative Medicine 3
PBS),sectionswerethenincubatedfor1hat37◦CwithHRP -
goat anti-rabbit diluted 1:200 in PBS. After three washes
for 5min in PBST, the sections were incubated in substrate
diaminobenzidine for 3–5min until the color developed.
Then, the sections were counterstaining with hematoxylin
for 3min. After brief washes in distilled water, the slides were
dehydrated in grades of ethanol, cleared for 20min in xylene.
PicturesweretakenbytheCanonMicro-imagingSystemand
analyzed with Image-Pro Plus 6.0 to measure average optical
intensity (AOI).
2.7. Western Blot for Endometrial IL-1β, IL-4, and IL-10 Pro-
teinDetection. Totalproteinwasextractedfromtheendome-
trial implantation site tissues which were homogenated
and lyzed in Mammal tissue protein extraction reagent,
supplemented with protease inhibitor cocktail and phenyl-
methylsulfonylﬂuoride (PMSF), then centrifuged at 13201g
for 10min at 4◦C. The supernatants were collected to
quantify the protein concentration with the BCA protein
assay kit. Uterine extracts (100μg protein) were mixed with
sample buﬀer, boiled for 10min, and ran on a 12% SDS-
PAGE gel (100v, 2h). Separated proteins on the gel were
transferred to nitrocellulose membranes. The membranes
were blocked with 5% non-fat-dry milk in PBST for 2h
at room temperature and incubated overnight at 4◦Cw i t h
antibodies to β-actin, IL-1β, IL-4, or IL-10 diluted 1:200,
1:50, 1:50, and 1:50, respectively. Following four washes
with PBST (5min each), the membranes were lucifugally
incubated with the DyLight 800-Labeled Antibody To Rabbit
IgG (H + L) diluted 1:10000 at room temperature for 1h.
After lucifugally washing with PBST, the membranes were
detected by near infrared double-color laser imaging system.
The pictures were analyzed with Image J to calculate the gray
scale ratio of β-actin.
2.8. Real-Time PCR for Endometrial IL-1β, IL-2, IL-4, and IL-
10 Expression. Total RNA was extracted from endometrial
homogenized tissue with Trizol reagent according to the
manufacturer’s instructions. RNA purity and concentration
were measured by Nucleic Acid/Protein Analyzer. 1μgo f
extracted total RNA was reverse transcribed with Prime-
Script RT reagent Kit in accordance with the manufacturer’s
instructions. The cDNA was kept at −20◦Cp r i o rt oP C R
ampliﬁcation. Real-Time PCR reactions were performed in
48 well optical PCR plates using an Applied Biosystems
StepOne Real-Time PCR System according to the manufac-
turer’s instructions. 2−ΔΔCT was used for analyzing the data.
Primer sequence:
β-actin
Forward primer: 5 -GGAGATTACTGCCCT-
GGCTCCTA-3 
Reverse primer: 5 -GACTCATCGTACTCC-
TGCTTGCTG-3 
IL-1β
Forward primer: 5 -GCTGTGGCAGCTACC-
TATGTCTTG-3 
Reverse primer: 5 -AGGTCGTCATCATCC-
CACGAG-3 
IL-2
Forward primer: 5 -GCAGCGTGTGTTGGA-
TTTGAC-3 
Reverse primer: 5 -GCTCATCATCGAATT-
GGCACTC-3 
IL-4
Forward primer: 5 -TGCACCGAGATGTTT-
GTACCAGA-3 
Reverse primer: 5 -TTGCGAAGCACCCTG-
GAAG-3 
IL-10
Forward primer: 5 -CAGACCCACATGCTC-
CGAGA-3 
Reverse primer: 5 -CAAGGCTTGGCAACC-
CAAGTA-3 
2.9. Statistics. All data had a normal distribution presented
asmean ±standarddeviation(SD)andanalysedbySPSS17.0
Statistical Software. Statistical signiﬁcance was determined
by one-way analysis of variance (ANOVA) followed by
Dunnett’s T3 test for data with equal variances not assumed.
For data with equal variances assumed, ANOVA followed
by LSD test was used. A probability of less than 0.05 was
considered to be statistically signiﬁcant.
3. Results
3.1. Implantation of Embryos on D8. Compared with group
N, the number of embryos was signiﬁcantly lower in group
M( P<0.05). In addition, the size of embryos was smaller
in group M than in group N. Compared with group M, the
number of embryos was signiﬁcantly higher in groups A and
H( P<0.05), and the size of embryos was larger in groups A
and H (Figure 1 and Table 1).
3.2. Expression of IL-1β, IL-2, IL-4, and IL-10 in Serum.
Compared with group N, the serum IL-1β level was signif-
icantly higher in group M on D5 and D6 (P<0.05). And
there was a signiﬁcant reduction in the expression of IL-1β
in groups A and H when compared with group M on D5
and D6 (P<0.05). Compare with group N, the serum IL-2
level was signiﬁcantly higher in group M on D6 and D8 (P<
0.05), while, compared with group M, there was a signiﬁcant
reduction in the expression of IL-2 in group A on D8 and in
group H on D6 and D8 (P<0.05). Compared with group N,
the serum IL-4 level was signiﬁcantly lower in group M on
D5 and D6 (P<0.05), while, compared with group M, there
wasasigniﬁcantincreaseintheexpressionofIL-4ingroupA
o nD 5a n di ng r o u pHo nD 5a n dD 8( P<0.05). Compared
with group N, the serum IL-10 level was signiﬁcantly lower
i ng r o u pMo nD 6( P<0.05). And there was a signiﬁcant4 Evidence-Based Complementary and Alternative Medicine
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Figure 1 :( a )U t e r u so fg r o u pNo nD 8 ;( b )u t e r u so fg r o u pMo nD 8 ;( c )u t e r u so fg r o u pAo nD 8 ;( d )u t e r u so fg r o u pHo nD 8 .
Table 1: Comparison of embryo number on Day 8.
Group Number of rats Embryo number
N 6 13.50 ± 2.27
M6 3 . 6 ± 1.52∗
A 6 9.88 ± 3.14Δ
H 6 11.58 ± 2.64Δ
Value = mean ± SD.
∗represents that there is signiﬁcant diﬀerence when M is compared with N
(P<0.05).
Δ represents that there is signiﬁcant diﬀerence when A or H is compared
with M (P<0.05).
increase in the expression of IL-10 in groups A and H when
compared with group M on D6 and D8 (P<0.05) (Table 2).
3.3. Expression of Endometrial IL-1β, IL-2, IL-4, and IL-10
Protein
3.3.1. Outcome of ELISA. The IL-1β protein concentration
was signiﬁcantly elevated in group M compared with group
No nD 5( P<0.05), while, compared with group M, there
was a signiﬁcant decrease in IL-1β protein concentration in
g r o u pAo nD 5a n dD 8a n di ng r o u pHo nD 5( P<0.05).
The IL-2 protein concentration was signiﬁcantly elevated in
group M compared with group N on D5 (P<0.05), while,
compared with group M, there was a signiﬁcant decrease
in IL-2 protein concentration in groups A and H on D5
(P<0.05). The IL-4 protein concentration was signiﬁcantly
r e d u c e di ng r o u pMc o m p a r e dw i t hg r o u pNo nD 5 ,D 6 ,
and D8 (P<0.05), while, compared with group M, there
was a signiﬁcant rise in IL-4 protein concentration in groups
A and H on D5, D6, and D8 (P<0.05). The IL-10
protein concentration was signiﬁcantly reduced in group M
compared with group N on D5 (P<0.05), while, compared
with group M, there was a signiﬁcant rise in IL-10 protein
concentration in groups A and H on D5 (P<0.05) (Table 3).
3.3.2. Outcome of Immunohistochemistry. Compared with
group N, the endometrial IL-1β protein level was signif-
icantly increasing in group M on D5, D6, and D8 (P<
0.05), while, compared with group M, there was a signiﬁcant
diminution in the expression of IL-1β p r o t e i ni ng r o u p sA
and H on D5 and D8 (P<0.05). Compared with group N,
the endometrial IL-2 protein level was signiﬁcantly increas-
ing in group M on D5, D6, and D8 (P<0.05), while, com-
pared with group M, there was a signiﬁcant diminution in
the expression of IL-2 protein in groups A and H on D5, D6,
andD8(P<0.05).ComparedwithgroupN,theendometrial
IL-4 protein level was signiﬁcantly decreasing in group M on
D5 and D6 (P<0.05), while, compared with group M, there
wasasigniﬁcantelevationintheexpressionofIL-4proteinin
groups A and H on D5 and D6 (P<0.05) (Figures 2 and 3).
3.3.3. Outcome of Western Blot. Compared with group N, the
endometrial IL-1β protein level was signiﬁcantly increasing
i ng r o u pMo nD 5a n dD 8( P<0.05), while, compared with
groupM,therewasasigniﬁcantdiminutionintheexpression
of IL-1β protein in groups A and H on D5 (P<0.05).
Compared with group N, the endometrial IL-4 protein level
was signiﬁcantly decreasing in group M on D5, D6, and
D8 (P<0.05), while, compared with group M, there was
a signiﬁcant elevation in the expression of IL-4 protein in
groups A and H on D5, D6, and D8 (P<0.05). Compared
with group N, the endometrial IL-10 protein level was
signiﬁcantly decreasing in group M on D5, D6, and D8 (P<
0.05), while, compared with group M, there was a signiﬁcant
elevationintheexpressionofIL-10proteiningroupAonD5
a n dD 6a n di ng r o u pHo nD 5a n dD 8( P<0.05) (Figure 4).
3.4. Expression of Endometrial IL-1β, IL-2, IL-4, and IL-10
mRNA. The IL-1β mRNA concentration was signiﬁcantly
l o w e ri ng r o u pMc o m p a r e dw i t hg r o u pNo nD 5( P<
0.05), while, compared with group M, there was a signiﬁcant
increase in IL-1β mRNA concentration in groups A and
Ho nD 5( P<0.05). The IL-2 mRNA concentration was
signiﬁcantly elevated in group M compared with group N on
D5, D6, and D8 (P<0.05), while, compared with group M,
there was a signiﬁcant decrease in IL-2 mRNA concentration
in group A on D5, D6, and D8 and in group H on D5 and D6
(P<0.05). The IL-4 mRNA concentration was signiﬁcantly
increasing in group M compared with group N on D5 andEvidence-Based Complementary and Alternative Medicine 5
Table 2: Comparison of serum cytokines concentration.
Cytokine group Day N M A H
IL-1β
D5 50.07 ±5.22 76.86 ± 15.35∗ 50.00 ± 6.81Δ 52.62 ± 7.58Δ
D6 50.50 ± 3.91 68.26 ± 1.25∗ 43.65 ± 4.38Δ 45.11 ± 1.84Δ
D8 27.12 ± 2.77 47.74 ± 9.44 46.57 ± 1.67 42.84 ± 2.83
IL-2
D5 86.13 ± 4.74 90.02 ± 7.03 74.84 ± 15.42 83.05 ± 11.64
D6 39.46 ± 8.84 61.02 ± 6.66∗ 57.70 ± 8.15 45.45 ± 7.82Δ
D8 37.24 ± 0.64 80.14 ± 6.66∗ 52.69 ± 11.69Δ 54.34 ± 9.05Δ
IL-4
D5 50.67 ± 2.08 16.33 ± 4.72∗ 43.00 ± 1.00Δ 30.00 ± 5.42Δ
D6 24.25 ± 2.50 17.00 ± 1.87∗ 18.40 ± 1.52 20.20 ± 3.63
D8 25.80 ± 7.26 18.00 ± 2.64 33.67 ± 12.89 44.00 ± 16.00Δ
IL-10
D5 141.87 ± 29.54 84.45 ± 7.35 93.88 ± 14.68 47.19 ± 1.48Δ
D6 113.07 ± 14.63 34.63 ± 13.02∗ 207.84 ± 40.27Δ 455.29 ± 37.66Δ
D8 37.33 ± 7.25 34.37 ± 7.24 69.78 ± 6.94Δ 60.51 ± 3.61Δ
Values are mean ± SD (pg/mL).
∗represents that there is signiﬁcant diﬀerence when M is compared with N (P<0.05).
Δ represents that there is signiﬁcant diﬀerence when A or H is compared with M (P<0.05).
Table 3: Comparison of endometrium cytokines protein concentration.
Cytokine group Day N M A H
IL-1β D5 35.47 ± 2.37 163.73 ± 6.62∗ 59.03 ± 20.02Δ 95.03 ± 3.36Δ
D6 52.80 ± 11.90 55.82 ± 14.90 49.13 ± 1.22 46.52 ± 10.4
D8 74.80 ± 11.75 111.55 ± 9.34 65.57 ± 3.01Δ 71.24 ± 23.91
IL-2 D5 51.78 ± 8.09 79.67 ± 10.65∗ 60.87 ± 9.83Δ 63.55 ± 12.06Δ
D6 40.63 ± 0.89 53.44 ± 5.63 44.51 ± 2.15 42.02 ± 3.83
D8 55.84 ± 3.48 68.81±11.49 66.47 ± 14.63 61.95 ± 12.82
IL-4 D5 189.50 ± 10.61 40.00 ± 10.89∗ 72.75 ± 23.04Δ 67.00 ± 13.47Δ
D6 58.33 ± 17.74 34.67 ± 9.50∗ 74.50 ± 16.05Δ 61.33 ± 7.09Δ
D8 66.33 ± 3.06 36.00 ± 5.57∗ 70.00 ± 18.88Δ 76.75 ± 23.04Δ
IL-10 D5 175.79 ± 9.42 127.94 ± 10.25∗ 185.32 ± 9.39Δ 161.02 ± 15.32Δ
D6 101.68 ± 21.22 268.95 ± 21.14∗ 256.29 ± 31.13 264.53 ± 20.55
D8 119.98 ± 31.77 60.12 ± 1.24 107.89 ± 18.16 126.30 ± 1.84Δ
Values are mean ± SD (pg/mL).
∗represents that there is signiﬁcant diﬀerence when M is compared with N (P<0.05).
Δ represents that there is signiﬁcant diﬀerence when A or H is compared with M (P<0.05).
D6 (P<0.05), while, compared with group M, there was
a signiﬁcant drop in IL-4 mRNA concentration in groups A
and H on D5, D6, and D8 (P<0.05). The IL-10 mRNA con-
centration was signiﬁcantly reduced in group M compared
with group N on D8 (P<0.05), while, compared with group
M, there was a signiﬁcant rise in IL-10 mRNA concentration
in groups A and H on D8 (P<0.05) (Figure 5).
4. Discussion
Mifepristone is the classical antagonist to progestin which
has obvious lysis to corpus luteum and resistance to im-
plantation [18]. The development of endometrium was
restrained by mifepristone in corpus luteal phase which
caused the nonsynchronous growth in endometrium and
blastocyst and interfered blastocyst implantation [19]. Mife-
pristone could blocks progesterone receptors, yet in this
study, progesterone counteracted the anti-implantation
eﬀect of mifepristone which suggests that excess proges-
terone could displace the anti-progesterone receptor. Ear-
lier research showed that acupuncture could reverse the
implantation resistance of mifepristone, upregulate P level,
and signiﬁcantly increase the average implantation blasto-
cysts number [20]. In the study, the average implantation
blastocysts number was notably higher in group A than in
group M, which conﬁrmed the eﬀect of acupuncture on
antagonizing mifepristone. Acupuncture could improve the
poor receptive state of endometrium due to mifepristone, so
as to promote the success of blastocyst implantation.
Successful pregnancy has been described as a “Th-2
phenomenon” [14]. Recently, signiﬁcantly higher serum
levels of Th2 cytokines, IL-6 and IL-10 were detected in
normal pregnancy compared with unexplained recurrent
pregnancy losses and signiﬁcantly higher serum levels of the
Th1 cytokine, IFN-γ were present in women with recurrent
pregnancy losses, compared with normal pregnancy [21].6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Immunohistochemical staining for the expression of endometrial IL-1β, IL-2, and IL-4. Original magniﬁcasion: ×400. Claybank
means positive expression. (a) IL-1β protein in each group on D5, D6, and D8; (b) IL-2 protein in each group on D5, D6, and D8; (c) IL-4
p r o t e i ni ne a c hg r o u po nD 5 ,D 6 ,a n dD 8 .I L - 1 β, IL-2, and IL-4 mainly expressed in luminal and glandular epithelium.
IL-2 is a Th1 cytokine that enhances the activity and
formation of cytotoxic cells. IL-2 also stimulates TNFα,I L -
1, and IFNγ secretion which are harmful to implantation
[22]. The blastocyst implantation of rat occurs on D4 or
D5. In this experiment, the expression of endometrial IL-
2m R N Aa n dp r o t e i nw e r en o t a b l yl o w e ri ng r o u p sN ,A ,
and H than in group M on D5, which veriﬁes that IL-2
is a harmful factor for implantation and demonstrates that
acupuncture could eﬀectively reduce the endometrial IL-2
mRNA and protein level and inhibit the cytotoxic eﬀect of
IL-2, so as to provide a better environment for blastocysts.
However, there is no signiﬁcant diﬀerence among groups
in serum IL-2 concentration until D6 or D8. The possible
reason might be that IL-2 is mainly produced in uterine
during the implantation phase, and there is a delay from
secreting in uterine to detecting in serum.
Many events that occur in the fetomaternal interface
involve IL-4. IL-4 secreted by endometrium-inﬁltrating
lymphocytes stimulates production of LIF in endometrial
tissue [23], which plays a crucial role in implantation and
placentation in several species [24]. IL-4 also promotes hCG
release in trophoblasts [25], and the released hCG induces
production of progesterone from the corpus luteum, which
promotes production of Th2 cytokines [26], and displays anEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Expression of endometrial IL-1β, IL-4, and IL-10 proteins on D5, D6, and D8 in (a) group N; (b) group M; (c) group A; (d) group
H.
antiabortiveeﬀect[27].Ourresultsindicatethatendometrial
IL-4proteinlevelwassigniﬁcantlyhigheringroupsN,A,and
H than in group M on D5, which is a cue that IL-4 plays a
positiveroleintheprocessofimplantation.Atthesametime,
the results show that acupuncture could promote implanta-
tion by elevating the expression of endometrial IL-4 protein.
IL-10 is one of the cytokines produced by Th2 lympho-
cytes, whose immunity is necessary for successful pregnancy
outcome [8]. IL-10 is an anti-inﬂammatory cytokine widely
present in tissues and ﬂuids during gestation [28], including
cyto- and syncytiotrophoblast as well as decidual mononu-
clear cells/macrophages and NK cells [8, 29, 30]. Decidual
monocytes/macrophages and NK cells spontaneously secrete
IL-4 and IL-10 in early pregnancy [30]. High levels of IL-10
have also been found in amniotic ﬂuid and maternal serum
[8,27,31,32].IL-10productionwasalsoincreasedincontrol
women compared with women that were unexplained infer-
tile [33]. A large increase in IL-10 from day 14 to day 2l of8 Evidence-Based Complementary and Alternative Medicine
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pregnancy in women with normal pregnancy outcome com-
pared with those with pregnancy failure was seen in another
study [34]. The protection function of IL-10 in implantation
is again conﬁrmed in this experiment. Acupuncture could
stimulate endometrium to produce IL-10 protein which has
resistancetotheeﬀectofmifepristone.SerumIL-10levelhad
a striking increase on D6 in groups N, A, and H compared
with group M which is not consistent with endometrial IL-
10 level. The delay may be taken into consideration.
In the recurrent implantation failure women, statistically
signiﬁcant elevated levels of IL-1β and reduced levels of IL-
10 were found [35]. IL-1 stimulates LIF receptor antagonist
and decreases implantation rate in the mouse [36]. A more
recent study has shown that low plasma concentrations
of IL-lβ and high plasma concentrations of IL-1 Ra are
associated with good-quality embryos and increased pres-
ence of clinical pregnancies [37]. IL-1β negatively aﬀects
early stages of pregnancy establishment acting as embryo
implantation inhibitors [38, 39]. In addition, Boomsma et
al. demonstrated that clinical pregnancy was associated with
a signiﬁcantly lower concentration of IL-1 in endometrial
secretions of women [40]. The results of IL-1β protein
level in this study suggest that IL-1β has a deletious eﬀect
on implantation as reported in other literatures and also
hint that endometrial IL-1β protein could be eﬀectively
reduced by acupuncture treatment. There is a discrepancy
between endometrial mRNA expression and protein level
in IL-1β, IL-4 which might be coursed by the regulation
for protein translation. The high protein level might give
a negative feedback to the mRNA expression. Endometrial
proteins of IL-4 and IL-10 were highest on D5 in group
N, but the peak time for group M was on D6 or even on
D8 which prompts that the expression of Th2 cytokines is
postponed by mifepristone which retards development of
endometriumleadingtoimplantationfailure.Thoughgroup
A reached the height on D6, acupuncture therapy improved
the poor receptive state of endometrium by stimulating the
expression of Th2 cytokines and reversed the harmful eﬀect
of mifepristone to some extent on D5.
In conclusion, we hypothesis that through a series of
nerve-physiology-endocrine activities, acupuncture changes
the immune microenvironment of endometrium by altering
the expression of cytokines in implantation failure uterus
including promoting Th2 cytokines such as IL-4 and IL-
10 secretion and inhibiting Th1 cytokines including IL-1β
and IL-2 secretion to improve blastocyst implantation. Next,
we have to do the corresponding clinical trials to prove
whether acupuncture can produce the same eﬀect in infertile
patients. Further rigorous research is needed to conﬁrm the
eﬀectiveness of acupuncture.
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